36495141|t|Comparative safety of sulfonylureas among U.S. nursing home residents.
36495141|a|BACKGROUND: The comparative safety of sulfonylureas (SUs) in nursing home (NH) residents remains understudied despite widespread use. We compared the effects of three SU medications and initial SU doses on adverse glycemic and cardiovascular events among NH residents. METHODS: This national retrospective cohort study linked Medicare claims with Minimum Data Set 2.0 assessments for long-stay NH residents aged >=65 years between January 2008 and September 2010. Exposures were the SU medication initiated (glimepiride, glipizide, or glyburide) and doses (standard or reduced). One-year outcomes were hospitalizations or emergency department visits for severe hypoglycemia, heart failure (HF), stroke, and acute myocardial infarction (AMI). After the inverse probability of treatment and inverse probability of censoring by death weighting, we estimated hazard ratios (HR) using Cox regression models with robust 95% confidence intervals (CI). RESULTS: The cohort (N = 6821) included 3698 new glipizide, 1754 glimepiride, and 1369 glyburide users. Overall, the mean (standard deviation) age was 81.4 (8.2) years, 4816 (70.6%) were female, and 5164 (75.7%) were White non-Hispanic residents. The rates of severe hypoglycemia were 30.3 (95% CI 22.3-40.1), 49.0 (95% CI 34.5-67.5), and 35.9 (95% CI 22.2-54.9) events per 1000 person-years among new glipizide, glimepiride, and glyburide users, respectively (glimepiride versus glipizide HR 1.6, 95% CI 1.0-2.4, p = 0.04; glyburide versus glipizide HR 1.2, 95% CI 0.7-1.9, p = 0.59). The rates of severe hypoglycemia were 27.1 (95% CI 18.6-38.0) and 42.8 (95% CI 33.6-53.8) events per 1000 person-years among new users of reduced and standard SU doses, respectively (HR 2.2, 95% CI 1.4-3.5, p < 0.01). Rates of HF, stroke, and AMI were similar between medications and doses. CONCLUSIONS: Among long-stay NH residents, new use of glimepiride and standard SU doses resulted in higher rates of severe hypoglycemic events. Cardiovascular outcomes may not be affected by the choice of SU medication or dose.
36495141	22	35	sulfonylureas	Chemical	MESH:D013453
36495141	109	122	sulfonylureas	Chemical	MESH:D013453
36495141	124	127	SUs	Chemical	MESH:D013453
36495141	238	240	SU	Chemical	MESH:D013453
36495141	265	267	SU	Chemical	MESH:D013453
36495141	554	556	SU	Chemical	MESH:D013453
36495141	579	590	glimepiride	Chemical	MESH:C057619
36495141	592	601	glipizide	Chemical	MESH:D005913
36495141	606	615	glyburide	Chemical	MESH:D005905
36495141	732	744	hypoglycemia	Disease	MESH:D007003
36495141	746	759	heart failure	Disease	MESH:D006333
36495141	761	763	HF	Disease	MESH:D006333
36495141	766	772	stroke	Disease	MESH:D020521
36495141	778	805	acute myocardial infarction	Disease	MESH:D009203
36495141	807	810	AMI	Disease	MESH:D009203
36495141	1065	1074	glipizide	Chemical	MESH:D005913
36495141	1081	1092	glimepiride	Chemical	MESH:C057619
36495141	1103	1112	glyburide	Chemical	MESH:D005905
36495141	1283	1295	hypoglycemia	Disease	MESH:D007003
36495141	1418	1427	glipizide	Chemical	MESH:D005913
36495141	1429	1440	glimepiride	Chemical	MESH:C057619
36495141	1446	1455	glyburide	Chemical	MESH:D005905
36495141	1477	1488	glimepiride	Chemical	MESH:C057619
36495141	1496	1505	glipizide	Chemical	MESH:D005913
36495141	1540	1549	glyburide	Chemical	MESH:D005905
36495141	1557	1566	glipizide	Chemical	MESH:D005913
36495141	1622	1634	hypoglycemia	Disease	MESH:D007003
36495141	1761	1763	SU	Chemical	MESH:D013453
36495141	1829	1831	HF	Disease	MESH:D006333
36495141	1833	1839	stroke	Disease	MESH:D020521
36495141	1845	1848	AMI	Disease	MESH:D009203
36495141	1947	1958	glimepiride	Chemical	MESH:C057619
36495141	1972	1974	SU	Chemical	MESH:D013453
36495141	2016	2028	hypoglycemic	Disease	MESH:C000721848
36495141	2098	2100	SU	Chemical	MESH:D013453
36495141	Positive_Correlation	MESH:D005905	MESH:D006333
36495141	Positive_Correlation	MESH:C057619	MESH:D007003
36495141	Positive_Correlation	MESH:D005913	MESH:D007003
36495141	Comparison	MESH:C057619	MESH:D005905
36495141	Comparison	MESH:D005905	MESH:D005913
36495141	Positive_Correlation	MESH:D005905	MESH:D007003
36495141	Comparison	MESH:C057619	MESH:D005913

